Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used. If ...

The Galleri test aims to find fragments of DNA in a person’s blood that can indicate the presence of a cancerous tumor.

A new Galleri blood test detected 75% of cancers without current screening options, with over half found in early stage I or ...

Cancer is the second leading cause of death worldwide. It accounts for an estimated 9.6 million deaths, or 1 in 6 deaths, in 2018, according to the World Health Organization (WHO). The numbers are ...

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

Data show screenings are pivotal to early detections especially in demographics where the disease is prevalent.

Signatera can detect tumor DNA in the bloodstream. A new blood test seeks to change the game in cancer management. Signatera, a "tumor-informed" blood test developed by Natera, can detect circulating ...

Treatments for cancer are continuously improving, but they can still cause debilitating, even fatal, side effects.

A clinical trial demonstrated that adding the Galleri multi-cancer early detection blood test to standard screening methods ...